BioSpace News Archive

Data suggests telehealth will remain despite many states reopening

Gravity Diagnostics, a CLIA laboratory headquartered in Covington, Kentucky, today announced the U.S. Food and Drug Administration (FDA) has granted an update to their Emergency Use Authorization (EUA) to include use of nasal swab specimens that are self-collected by individuals using the Kroger Health COVID-19 Test Home Collection Kit.

The COVID-19 coronavirus pandemic forced oncology nurses to navigate abnormal circumstances, both at home and at work.

Venus Concept Inc. announced that it has received FDA 510 clearance to market and sell Venus Viva MD. Venus Viva MD is a non-invasive device intended to be used by aesthetic-related physicians or dermatologists.

Cytokinetics, Incorporated (Nasdaq: CYTK), today announced that it will host a Virtual Investor and Analyst Day on Wednesday, July 15, 2020 from 8:30 AM to 11:30 AM ET.

BioLife Solutions, Inc. (NASDAQ: BLFS) (“BioLife” or the “Company”), a leading developer and supplier of a portfolio of class-defining bioproduction tools for cell and gene therapies, today announced it intends to offer shares of its common stock for sale in an underwritten public offering.

Invacare Corporation (NYSE:IVC)(the “Company”), a leading manufacturer and distributor of medical equipment used in non-acute care settings, today announced that Matthew E. Monaghan, chairman, president and chief executive officer will present at the 20th Annual New Ideas Summer Conference on Tuesday, July 14, 2020.

Regulatory News: Eurofins Technologies (Paris:ERF) announces the launch of CE-IVD marked rapid point-of-care testing devices to identify a person’s past exposure to COVID-19 (SARS-CoV-2) in only 10 minutes. The serology-based, finger-prick tests detect virus antibodies with a sensitivity of 94.5% from 19 days following the onset of symptoms. The CE-IVD marked INgezim ® COVID-19 CROM dual-recognition immunochromato

Dr. Reddy’s Laboratories Ltd. announces partnering with FUJIFILM Corporation through FUJIFILM Toyama Chemical Co. Ltd. and Global Response Aid for the development, manufacture and sales of Avigan® Tablets, a potential treatment of COVID-19.

Luminex Corporation announced that the company has delivered the first of its new xMAP® INTELLIFLEX Systems to several of its Life Science Research Partners, achieving a major milestone in the company’s strategy to extend its xMAP Technology with new functionality to facilitate new applications.